The Chemours Company’s High‑Yield Senior Notes Offering

Cravath represented the initial purchasers in connection with the $600 million 144A/Reg. S high-yield senior notes offering of The Chemours Company, a leading, global provider of performance chemicals. The transaction closed on November 27, 2024.

The Cravath team included partner Craig F. Arcella and associate Maurice Temming on capital markets matters; partner Arvind Ravichandran and associates Jessica Shung and Ruth Goldstein Schapiro on tax matters; and partner Matthew Morreale and associate Star S. Gulant on environmental matters. Liza Park also worked on capital markets matters.